Overview
H&H INTL HLDG (1112)
Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells pediatric nutrition, baby care, adult nutrition...
- Open
- 25.220
- High
- 26.500
- Low
- 24.840
- Prev. Close
- 25.220
- Volume
- 2.40M
- Turnover
- 62.25M
- Avg Price
- 25.911
- Bid/Ask Ratio
- -28.57%
- Amplitude
- 6.58%
- 52wk High
- 26.500
- Volume Ratio
- 1.02
- Turnover Ratio
- 0.37%
- 52wk Low
- 9.280
- HK Mkt Cap
- 16.86B
- Market CapHKD
- 16.86B
- P/ETTM
- 19.91
- P/EDynamic
- 11.99
- P/EStatic
- --
- EPSTTM
- 1.31
- EPSDynamic
- 2.18
- EPSStatic
- --
- BVPS
- 11.62
- P/B
- 2.25
- HK Shares
- 645.56M
- Dividend YieldTTM
- 3.75%
- DividendTTM
- 0.98
- Shares
- 645.56M
- Min lot size
- 500
- Currency
- HKD
H&H INTL HLDG Analyst Rating
View moreForecast & Rating
Nov 2, 2026- Strong buy77.78%
- Buy22.22%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 7
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
Daily Events
- Jul, 3
Health and Happiness (H&H) International Holdings (1112.HK) staged a low-open rally, closing up 6.59% at HK$11.32, fueled by strong Q4 earnings and bullish institutional sentiment. The stock opened at HK$10.68 and rebounded sharply, hitting an intraday high of HK$11.47 with total turnover of approximately HK$21.15 million. Q4 operating revenue rose 20.55% YoY to HK$4.078 billion, net profit surged 136.38% YoY to HK$69.57 million, and EPS jumped 136.32% YoY to HK$0.1084, underscoring a significant profitability turnaround. CLSA and China Merchants Securities recently reiterated Buy ratings. However, the stock remains down 13.85% year-to-date and 32.62% off its 52-week high of HK$16.80, now trading above its 20-day MA (HK$10.80) but below the 60-day MA (HK$12.36), leaving the divergence between short-term momentum and medium-term trend as a cautionary note.
- Jul, 2
健合国际今日低开高走,开盘短暂下探 10.26 港元的日内低点后震荡上行,下午盘一度触及 10.70 港元高位,最终收报 10.60 港元,较前收 10.18 港元涨 4.1%。推动股价的主要利好来自一季度财报改善,营收 40.78 亿港元同比增长 20.55%,净利润 6957 万港元同比猛增 136.38%,EPS 达 0.1084 港元,较上年同期增逾 1.3 倍。此外,CLSA 与招商证券近期重申买入评级,且公司于世界微生物日推广婴幼儿益生菌新品,强化了市场情绪。不过,当前股价距 52 周高点 16.8 港元仍下滑 36.9%,且低于 20 日均线 (10.805 港元) 和 60 日均线 (12.377 港元),估值修复尚需更多业绩确认。
News
AASTOCKS News · Citi: H&H INTL HLDG Management Maintains Full-Year Earnings Guidance
Market Movers · H&H International Holdings hits 52-week high
AASTOCKS News · M Stanley Reiterates Constructive View on Yum China Holdings, Inc. , H&H INTL HLDG and Chagee Holdings Limited After China Consumer Survey
Simplywall · Health And Happiness H&H International Holdings (SEHK:1112) Sales Update Raises The Valuation Question
Weekly Review · Weekly Recap | H&H INTL HLDG +3.07%, hitting a 52-week high intraday
